Stay updated on Viatris Press Releases
Sign up to get notified when there's something new on the Viatris Press Releases page.

Latest updates to the Viatris Press Releases page
- CheckyesterdayChange DetectedA new press release announces WAKIX approval in Japan, signaling regulatory progress in a key market. The listing of the Chief Financial Officer transition has been removed from the press releases.SummaryDifference7%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check43 days agoChange DetectedTwo August 2026 press releases were added to the Viatris Newsroom: Q2 financial results and a quarterly dividend. Several earlier 2026 items were removed, including the May 1 release on data presentations and the April 13 release about the May 7 financial results.SummaryDifference7%

- Check51 days agoChange DetectedA new press release entry for July 29, 2026 announcing FDA approval of Gwyn Lo contraceptive patch was added. The April 10, 2026 data presentations entry was removed from the list.SummaryDifference8%

- Check65 days agoChange DetectedNo textual changes were detected in the page changes data. The press releases list appears unchanged.SummaryDifference0.3%

- Check79 days agoChange DetectedTwo new press release items were added to the listing: July 1, 2026 announcing the second-quarter 2026 financial results and June 29, 2026 reporting positive topline results from a Phase 3 study. Additionally, older March 2026 entries were removed from the listing.SummaryDifference7%

- Check122 days agoChange DetectedA new press release dated May 18, 2026 about the FDA accepting Viatris' NDA for fast-acting meloxicam was added, and the February 26, 2026 financial results release was removed from the list.SummaryDifference7%

Stay in the know with updates to Viatris Press Releases
Enter your email address, and we'll notify you when there's something new on the Viatris Press Releases page.